Strength
150 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462037030
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA210278On Market Since
2/1/2021
Pharmacological Classes
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Related Drugs
Same classification
GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0211
per EA